0

No products in the cart.

0

No products in the cart.

Home Business Outlook Therapeutics director Ghiath Sukhtian buys $2.5m in shares
Business

Outlook Therapeutics director Ghiath Sukhtian buys $2.5m in shares

Updated 1 hour Ago1 Mins read0 Views
Share
Outlook Therapeutics director Ghiath Sukhtian buys .5m in shares
Share


Outlook Therapeutics director Ghiath Sukhtian buys $2.5m in shares

Source link

Share
Exclusive-Anthropic IPO valuation hinges on 0-200 billion 2028 revenue forecast, sources say Previous post Exclusive-Anthropic IPO valuation hinges on $190-200 billion 2028 revenue forecast, sources say

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Oruka Therapeutics GC Paul Quinlan sells .64m stock
Business

Oruka Therapeutics GC Paul Quinlan sells $5.64m stock

12 minutes Ago
Lifeway Foods director Edward Smolyansky sells .9m in shares
Business

Lifeway Foods director Edward Smolyansky sells $2.9m in shares

23 minutes Ago
Oruka Therapeutics GC Paul Quinlan sells .64m stock
Business

Angel Studios director Steven Sarowitz acquires $1.36m in ANGX stock

33 minutes Ago
Putin says Russia, North Korea coordinating on regional security
Business

Putin says Russia, North Korea coordinating on regional security

45 minutes Ago

Keep in touch

Subscribe to our newsletter to get our newest articles instantly!

    Copyright 2025. All rights reserved

    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com